Muscarinic M1 Receptor Overstimulation Disrupts Working Memory Activity for Rules in Primate Prefrontal Cortex

Neuron. 2018 Jun 27;98(6):1256-1268.e4. doi: 10.1016/j.neuron.2018.05.027. Epub 2018 Jun 7.

Abstract

Acetylcholine release in the prefrontal cortex (PFC), acting through muscarinic receptors, has an essential role in regulating flexible behavior and working memory (WM). General muscarinic receptor blockade disrupts PFC WM representations, while selective stimulation of muscarinic receptor subtypes is of great interest for the treatment of cognitive dysfunction in Alzheimer's disease. Here, we tested selective stimulation and blockade of muscarinic M1 receptors (M1Rs) in macaque PFC, during performance of a cognitive control task in which rules maintained in WM specified saccadic responses. We hypothesized that M1R blockade and stimulation would disrupt and enhance rule representation in WM, respectively. Unexpectedly, M1R blockade did not consistently affect PFC neuronal rule selectivity. Moreover, M1R stimulation suppressed PFC activity, and at higher doses, degraded rule representations. Our results suggest that, in primates, the deleterious effects of general muscarinic blockade on PFC WM activity are not mediated by M1Rs, while their overstimulation deteriorates PFC rule maintenance.

Keywords: abstract rules; acetylcholine; allosteric modulator; antisaccade; iontophoresis; muscarinic M1 receptor; muscarinic receptors; neurophysiology; prefrontal cortex; working memory.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride / pharmacology
  • Allosteric Regulation
  • Animals
  • Benzamides / pharmacology
  • Iontophoresis
  • Macaca mulatta
  • Memory, Short-Term / drug effects*
  • Memory, Short-Term / physiology
  • Muscarinic Agonists / pharmacology*
  • Muscarinic Antagonists / pharmacology*
  • Neurons / drug effects*
  • Neurons / metabolism
  • Pirenzepine / pharmacology
  • Prefrontal Cortex / drug effects*
  • Prefrontal Cortex / metabolism
  • Prefrontal Cortex / physiopathology
  • Receptor, Muscarinic M1 / agonists*
  • Receptor, Muscarinic M1 / antagonists & inhibitors*
  • Receptor, Muscarinic M1 / metabolism

Substances

  • Benzamides
  • Muscarinic Agonists
  • Muscarinic Antagonists
  • Receptor, Muscarinic M1
  • VU0357017
  • Pirenzepine
  • (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride